Dr. Patricia Lynn Sutton, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 425 Chester Pike, Norwood, PA 19074 Phone: 610-532-0646 Fax: 610-532-1252 |
News Archive
Summer time means shorts, tank tops, bathing suits – in other words, lots of exposure to the damaging UV rays of the sun. With more skin exposed, now is an especially good time to check for signs of skin cancer.
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
The Arua Hospital AIDS Program today commemorated two years of providing free access to antiretroviral (ARV) treatment for nearly 1,100 people living with HIV/AIDS in Arua, a rural region in northwestern Uganda.
Surgeons are tweaking existing computer technologies to enhance their visualization of cancerous tumors and persistent wounds according to two studies presented this week at the 2014 American College of Surgeons Clinical Congress.
› Verified 9 days ago